| Attributes | Values |
|---|
| rdf:type
| |
| description
| - videnskabelig artikel (da)
- article científic (ca)
- articolo scientifico (it)
- artigo científico (pt)
- bilimsel makale (tr)
- vedecký článok (sk)
- vetenskaplig artikel (sv)
- vědecký článek (cs)
- wetenschappelijk artikel (nl)
- wissenschaftlicher Artikel (de)
- научни чланак (sr)
- bài báo khoa học (vi)
- article scientifique (fr)
- artículu científicu espublizáu en 2009 (ast)
- наукова стаття, опублікована в грудні 2009 (uk)
- scientific article published on 23 December 2009 (en)
- مقالة علمية نشرت في 23 ديسمبر 2009 (ar)
|
| publication date
| |
| publication date
| |
| language of work or name
| |
| language of work or name
| |
| rdfs:label
| - The metabolic syndrome: validity and utility of clinical definitions for cardiovascular disease and diabetes risk prediction (en)
- The metabolic syndrome: validity and utility of clinical definitions for cardiovascular disease and diabetes risk prediction (nl)
- The metabolic syndrome: validity and utility of clinical definitions for cardiovascular disease and diabetes risk prediction (ast)
|
| skos:prefLabel
| - The metabolic syndrome: validity and utility of clinical definitions for cardiovascular disease and diabetes risk prediction (en)
- The metabolic syndrome: validity and utility of clinical definitions for cardiovascular disease and diabetes risk prediction (nl)
- The metabolic syndrome: validity and utility of clinical definitions for cardiovascular disease and diabetes risk prediction (ast)
|
| name
| - The metabolic syndrome: validity and utility of clinical definitions for cardiovascular disease and diabetes risk prediction (en)
- The metabolic syndrome: validity and utility of clinical definitions for cardiovascular disease and diabetes risk prediction (nl)
- The metabolic syndrome: validity and utility of clinical definitions for cardiovascular disease and diabetes risk prediction (ast)
|
| author
| |
| author
| |
| title
| |
| title
| - The metabolic syndrome: validity and utility of clinical definitions for cardiovascular disease and diabetes risk prediction (en)
|
| page(s)
| |
| page(s)
| |
| instance of
| |
| instance of
| |
| main subject
| |
| main subject
| |
| PubMed ID
| |
| PubMed ID
| |
| PubMed ID
| |
| published in
| |
| published in
| |
| issue
| |
| volume
| |
| issue
| |
| volume
| |
| DOI
| |
| DOI
| |
| DOI
| - 10.1016/J.MATURITAS.2009.11.026
|
| Fatcat ID
| |
| Fatcat ID
| - release_iyub2daob5e2vlqle6smp2iogm
|
| ResearchGate publication ID
| |
| ResearchGate publication ID
| |
| is about
of | |
| is cites work
of | - Approach to identifying and managing atherogenic dyslipidemia: a metabolic consequence of obesity and diabetes
- Metabolic syndrome and periodontitis in Gullah African Americans with type 2 diabetes mellitus
- B-type natriuretic peptide as an independent correlate of nocturnal voiding in Japanese women.
- One risk assessment tool for cardiovascular disease, type 2 diabetes, and chronic kidney disease
- Association between obesity and reduced body temperature in dogs.
- Bisphenol A and indicators of obesity, glucose metabolism/type 2 diabetes and cardiovascular disease: a systematic review of epidemiologic research
- Chronopharmacokinetics of drugs in toxicological aspects: A short review for pharmacy practitioners
- Metabolic syndrome in central Brazil: prevalence and correlates in the adult population
- The Relationship of Metabolic Syndrome with Stress, Coronary Heart Disease and Pulmonary Function--An Occupational Cohort-Based Study
- The Reversal Intervention for Metabolic Syndrome (TRIMS) study: rationale, design, and baseline data
- PPARs in Rhythmic Metabolic Regulation and Implications in Health and Disease
- A new look at the genetic and environmental coherence of metabolic syndrome components
- Cardiometabolic risk factors are associated with high urinary enterolactone concentration, independent of urinary enterodiol concentration and dietary fiber intake in adults
- Treatment of antipsychotic-associated obesity with a GLP-1 receptor agonist--protocol for an investigator-initiated prospective, randomised, placebo-controlled, double-blinded intervention study: the TAO study protocol.
- Façons d’identifier et de prendre en charge la dyslipidémie athérogène: Une conséquence métabolique de l’obésité et du diabète
- Correlation between Hormonal Statuses and Metabolic Syndrome in Postmenopausal Women
- Effectiveness of physical activity intervention among government employees with metabolic syndrome.
- Role of dihydropyridinic calcium channel blockers in the management of hypertension.
- Relationship between reproductive aging, body composition, hormonal status and metabolic syndrome in postmenopausal women.
- Circulatory syndrome: an evolution of the metabolic syndrome concept!
- Association between salivary pH and metabolic syndrome in women: a cross-sectional study
|
| is cites work
of | |
![[RDF Data]](/fct/images/sw-rdf-blue.png)
![[cxml]](/fct/images/cxml_doc.png)
![[csv]](/fct/images/csv_doc.png)
![[text]](/fct/images/ntriples_doc.png)
![[turtle]](/fct/images/n3turtle_doc.png)
![[ld+json]](/fct/images/jsonld_doc.png)
![[rdf+json]](/fct/images/json_doc.png)
![[rdf+xml]](/fct/images/xml_doc.png)
![[atom+xml]](/fct/images/atom_doc.png)
![[html]](/fct/images/html_doc.png)